The Filing Desk

American Vanguard

AVD · NYSE · Materials · Financials, fiscal 2016 to 2025

AVD · Last close · November 19, 2026
$0.69
Value American Vanguard yourself

American Vanguard's revenue fell 5.9% to $515 million in fiscal 2025. Its operating margin was −5.5%, up from −18.6% a year earlier. Free cash flow was −$25 million. The diluted share count rose 1.3%.

AMERICAN VANGUARD CORPORATION Latest fiscal year ended December 31, 2025 10-K filed March 16, 2026 · 0001193125-26-108593 Updated
Revenue
$515M
5.9%
Operating margin
−5.5%
13.1 pts
Net income
−$50M
 
Free cash flow
−$25M
 
Return on capital
−6.2%
12.3 pts
Market cap
$20M
Nov 19 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What American Vanguard does

American Vanguard makes and sells chemicals and biological products that protect crops, lawns, ornamental plants and animals from insects, weeds, fungi and other pests. Its range includes insecticides, herbicides, fungicides, soil fumigants, plant nutrition and growth regulators, sold as liquids, powders and granules. It also sells some products in closed containers that farmers load straight into their equipment without handling the chemical.

The company reports one business segment. Its main U.S. subsidiary, AMVAC, sells mostly through national distributors and buying groups, which resell to retailers and growers. Abroad it has sales offices or its own distributors in Central and South America, Australia, New Zealand and India. Its three largest customers made up 13%, 12% and 12% of sales in 2025. It says it competes with U.S. and foreign makers, many of them larger, on quality, how well products work, price and service.

American Vanguard is based in Newport Beach, California, runs six manufacturing plants and had 739 employees at the end of 2025. Demand is seasonal and follows growing seasons, weather and pest pressure. In 2025 it worked on a plan to cut supply chain and factory costs and simplify how it is organized. Its products must be registered with the U.S. Environmental Protection Agency, each state and foreign regulators.

Its biggest risks, as it describes them

  • Regulators could limit or cancel some of its pesticides, as with the EPA's findings on DCPA and petitions against its organophosphate products.
  • Lawsuits claiming harm from its products, and state laws banning certain pesticides, could hurt its results.
  • Its new debt terms limit its cash, require minimum financial performance and carry significant interest costs.
  • Bad weather and low crop prices can cut demand from farmers for its products.
  • Disruptions in its global supply chain, including sourcing outside the U.S., and tariffs could raise costs or cut supply.
From American Vanguard's annual report on Form 10-K, filed March 16, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2023, earnings per share fell 7.2% a year and net income 7.4% a year, while buybacks cut the share count by 3%. American Vanguard then lost money in fiscal 2024 and 2025.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments1620111212
Debt incl. finance leases5252139147174
Net debt (negative means net cash)3631128135162
Net debt to EBITDA0.9x0.6x4.3x——
Debt to equity0.1x0.1x0.4x0.6x0.9x
Interest coverage8.4x10.3x1.8x−6.1x−1.5x
Current ratio1.5x1.5x1.9x1.6x1.8x
Quick ratio0.8x0.8x0.9x0.9x0.9x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project American Vanguard's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What American Vanguard says to expect

  • Full year 2026: adjusted EBITDA and salesRevise Full-Year Outlook; Adjusted EBITDA $36 million to $40 million on Sales of $500 million to $530 million
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 10, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, 3 insiders bought $237,110 of American Vanguard shares on the open market, and 1 insider sold $1.2 million.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Aug 18, 2026Cruiser Capital Advisors LLCOtherSold556,580$2.20$1.2 millionForm 4
Aug 17, 2026Steven D MacicekDirectorBought19,000$2.09$39,710Form 4
Jun 3, 2026Douglas KayeChief Executive OfficerBought5,000$2.50$12,500Form 4
May 19, 2026Patrick E GottschalkDirectorBought25,000$2.70$67,500Form 4
May 13, 2026Patrick E GottschalkDirectorBought20,000$2.95$59,000Form 4
May 12, 2026Patrick E GottschalkDirectorBought20,000$2.92$58,400Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score3 of 93 of 95 of 9
Rule of 40−17.1%−6.2%−10.8%
Altman Z''4.322.092.80
Accruals ratio8.9%−18.6%−4.7%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassFailFail
Cash from operations is positiveFailPassFail
Return on assets roseFailFailPass
Cash from operations exceeds net incomeFailPassPass
Debt fell relative to assetsFailFailFail
Current ratio rosePassFailPass
Share count didn't risePassPassFail
Gross margin roseFailFailPass
Revenue rose relative to assetsFailFailPass
F-score3 of 93 of 95 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put American Vanguard side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
American VanguardFY25−5.9%−5.5%−4.9%−6.2%—5
LSB IndustriesFY2517.8%9.3%2.9%5.3%2.2x8Compare
Intrepid PotashFY2517.1%3.6%8.6%———Compare
Compass MineralsFY2511.3%2.0%10.3%1.8%6.1x5Compare
Scotts Miracle-GroFY25−3.9%10.5%8.0%13.4%4.8x6Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue312355454468459558610579547515
Revenue growth7.9%13.8%27.9%3.1%−2.0%21.6%9.3%−5.0%−5.5%−5.9%
Gross profit128147183177173171192179120148
Research and development21262624262932383323
Operating income2027392623314123−102−28
Net income132024141519278−126−50
Diluted EPS (US$)0.440.680.810.460.510.610.920.26−4.50−1.75
Diluted shares (millions)29303030303030282828
Cash flow
Cash from operations46591210908657−594−21
Capital expenditure1178131110131274
Free cash flow36524−3797744−71−3−25
Dividends paid1222123320
Share buybacks007305341600
Acquisitions082203819100500
Stock-based compensation3567776642
Balance sheet at fiscal year end
Cash and short-term investments81167161620111212
Debt incl. finance leases4178971491075252139147174
Total assets430536594670680694726768637596
Total liabilities148230264326320321356398404404
Shareholders' equity282305329344361373370370233192
Margins and ratios
Gross margin41.1%41.5%40.2%37.9%37.6%30.6%31.6%30.9%22.0%28.6%
Operating margin6.6%7.5%8.6%5.6%5.0%5.5%6.7%4.0%−18.6%−5.5%
Net margin4.1%5.7%5.3%2.9%3.3%3.3%4.5%1.3%−23.1%−9.7%
Free cash flow margin11.5%14.7%0.8%−0.7%17.2%13.8%7.2%−12.2%−0.6%−4.9%
Rule of 40 (growth + FCF margin)19.3%28.5%28.7%2.3%15.2%35.4%16.5%−17.1%−6.2%−10.8%
Return on capital4.5%6.4%7.2%4.2%4.1%5.0%7.7%3.8%−18.5%−6.2%
Return on equity4.7%6.9%7.6%4.0%4.3%5.1%7.4%2.0%−41.9%−23.4%
Return on assets3.0%4.2%4.3%2.1%2.3%2.7%3.9%1.0%−18.0%−8.1%
Net debt to EBITDA0.9x1.5x1.6x3.2x2.1x0.9x0.6x4.3x——
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: American Vanguard's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with American Vanguard.